About This Video

If you had a genetic mutation that made you 15 times more likely to develop Alzheimer’s disease, would you want to know? How would you react to such knowledge? Epidemiologist Robert C. Green discusses possible implications of disclosing genetic information to patients with a high-risk factor for Alzheimer’s. And the director of the National Institutes of Health and former leader of the Human Genome Project, Francis Collins, explains strategies for interpreting genetic tests in the emerging age of personalized genomic medicine.

Recorded June 2010; Posted October 2010